Paper40328660
Immune cells mediate the effect of plasma lipidomes on IgA nephropathy: a Mendelian randomization study.
Li Q and 6 others. Ren Fail, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Immune cells mediate the effect of plasma lipidomes on IgA nephropathy: a Mendelian randomization study. Papers, record 40328660. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40328660
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Immune cells mediate the effect of plasma lipidomes on IgA nephropathy: a Mendelian randomization study.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glomerulonephritis, IGA | Major topic |
| Lipids | Major topic |
| Humans | |
| Mendelian Randomization Analysis | |
| Genome-Wide Association Study | |
| Lipidomics | |
| Polymorphism, Single Nucleotide |
Source PubMed
References59
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28849060 | Association of BAFF with PI3K/Akt/mTOR signaling in lupus nephritis. | Mol Med Rep | 2017 | https://conductscience.org/library/papers/28849060 | PubMed |
| 2 | 30046527 | GSK3β inhibits epithelial-mesenchymal transition via the Wnt/β-catenin and PI3K/Akt pathways. | Int J Ophthalmol | 2018 | https://conductscience.org/library/papers/30046527 | PubMed |
| 3 | 29686387 | Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. | Nat Genet | 2018 | https://conductscience.org/library/papers/29686387 | PubMed |
| 4 | 34594039 | A cross-population atlas of genetic associations for 220 human phenotypes. | Nat Genet | 2021 | https://conductscience.org/library/papers/34594039 | PubMed |
| 5 | 38904014 | The PI3K/Akt Pathway and Glucose Metabolism: A Dangerous Liaison in Cancer. | Int J Biol Sci | 2024 | https://conductscience.org/library/papers/38904014 | PubMed |
| 6 | 35680856 | Signaling pathways of chronic kidney diseases, implications for therapeutics. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/35680856 | PubMed |
| 7 | 18222349 | IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy. | Semin Nephrol | 2008 | https://conductscience.org/library/papers/18222349 | PubMed |
| 8 | 19193778 | Probability, predictors, and prognosis of posttransplantation glomerulonephritis. | J Am Soc Nephrol | 2009 | https://conductscience.org/library/papers/19193778 | PubMed |
| 9 | 38601154 | Effect of smoking-related features and 731 immune cell phenotypes on esophageal cancer: a two-sample and mediated Mendelian randomized study. | Front Immunol | 2024 | https://conductscience.org/library/papers/38601154 | PubMed |
| 10 | 37015244 | Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial. | Lancet | 2023 | https://conductscience.org/library/papers/37015244 | PubMed |
| 11 | 20200498 | The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. | Kidney Int | 2010 | https://conductscience.org/library/papers/20200498 | PubMed |
| 12 | 24114802 | Mendelian randomization analysis with multiple genetic variants using summarized data. | Genet Epidemiol | 2013 | https://conductscience.org/library/papers/24114802 | PubMed |
| 13 | 36380372 | Association between gut microbiota and preeclampsia-eclampsia: a two-sample Mendelian randomization study. | BMC Med | 2022 | https://conductscience.org/library/papers/36380372 | PubMed |
| 14 | 34211460 | Dietary Supplementation With Eicosapentaenoic Acid Inhibits Plasma Cell Differentiation and Attenuates Lupus Autoimmunity. | Front Immunol | 2021 | https://conductscience.org/library/papers/34211460 | PubMed |
| 15 | 21949093 | The pathophysiology of IgA nephropathy. | J Am Soc Nephrol | 2011 | https://conductscience.org/library/papers/21949093 | PubMed |
| 16 | 33961203 | Mendelian randomisation for mediation analysis: current methods and challenges for implementation. | Eur J Epidemiol | 2021 | https://conductscience.org/library/papers/33961203 | PubMed |
| 17 | 26210045 | Hyaluronan carried by tumor-derived microvesicles induces IL-10 production in classical (CD14++CD16-) monocytes via PI3K/Akt/mTOR-dependent signalling pathway. | Immunobiology | 2017 | https://conductscience.org/library/papers/26210045 | PubMed |
| 18 | 34528858 | Quercetin alleviates chronic renal failure by targeting the PI3k/Akt pathway. | Bioengineered | 2021 | https://conductscience.org/library/papers/34528858 | PubMed |
| 19 | 38622701 | The impact of lipidome on breast cancer: a Mendelian randomization study. | Lipids Health Dis | 2024 | https://conductscience.org/library/papers/38622701 | PubMed |
| 20 | 38498274 | The role of PI3K/Akt signaling pathway in chronic kidney disease. | Int Urol Nephrol | 2024 | https://conductscience.org/library/papers/38498274 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42820075 | Advances in Exosome Research in Renal Cell Carcinoma: Mechanisms, Biomarkers, and Therapeutic Applications. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42820075 | PubMed |
| 42799236 | Potential Causal Association Between Plasma Lipidomes and Keloid: Analysis from a Two-Sample Mendelian Randomization. | Clin Cosmet Investig Dermatol | 2026 | https://conductscience.org/library/papers/42799236 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40328660
GET https://conductscience.org/api/papers/v1/40328660/references?page=2